talazoparib,rucaparib,abiraterone,enzalutamide
pfizer,astellas,clovis oncology
['brca', 'triton-3', 'crpc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'talapro-2']
 #gu23 discussing talapro-2 &amp; triton-3 abstracts. ongoing qs/challenges: 1. where will parpi best fit ? 1l mcrpc? 2l mcrpc? mhspc? 2. which pts? brca? all-comers? 3. managing toxicities eg anemia 4. overcoming resistance eg reversion mutations 
GU Med Onc, A/Prof Peter Mac/UoM, ANZUP Translational Chair, #UpfrontPSMA Alliance, COSA Urologic Oncology Chair, NHMRC L1 Investigator. Opinions my own.